Dissecting cancer evolution at the macro-heterogeneity and micro-heterogeneity scale. (February 2015)

• Record Type: Journal Article
• Authors: Barber, Louise J; Davies, Matthew N; Gerlinger, Marco
• Is Part Of: Current opinion in genetics & development. Volume 30(2015)
• Page Start: 1
• Page End: 6
• Publication Date: 2015-02
• Subjects: Genetics -- Periodicals; Developmental biology -- Periodicals; Developmental genetics -- Periodicals; 576.5
• DOI: 10.1016/j.gde.2014.12.001
• Languages: English
• ISSNs: 0959-437X

Abstract

Abstract : Intratumour heterogeneity complicates biomarker discovery and treatment personalization, and pervasive cancer evolution is a key mechanism leading to therapy failure and patient death. Thus, understanding subclonal heterogeneity architectures and cancer evolution processes is critical for the development of effective therapeutic approaches which can control or thwart cancer evolutionary plasticity. Current insights into heterogeneity are mainly limited to the macroheterogeneity level, established by cancer subclones that have undergone significant clonal expansion. Novel single cell sequencing and blood-based subclonal tracking technologies are enabling detailed insights into microheterogeneity and the dynamics of clonal evolution. We assess how this starts to delineate the rules governing cancer evolution and novel angles for more effective therapeutic intervention.